Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Focus on melanoma.

Literature DB >> 12398891

Focus on melanoma.

Alan N Houghton¹, David Polsky.

Abstract

Entities: Disease

Mesh：

Year: 2002 PMID： 12398891 DOI： 10.1016/s1535-6108(02)00161-7

Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743

Keyword Cloud
Cited

× No keyword cloud information.

63 in total

1. MMP2 expression is a prognostic marker for primary melanoma patients.

Authors: Anand Rotte; Magdalena Martinka; Gang Li
Journal: Cell Oncol (Dordr) Date: 2012-06-06 Impact factor: 6.730

2. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

Authors: Murielle Mimeault; Surinder K Batra
Journal: World J Clin Oncol Date: 2012-03-10

Review 3. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.

Authors: Gerd P Pfeifer; Ahmad Besaratinia
Journal: Photochem Photobiol Sci Date: 2011-08-01 Impact factor: 3.982

Review 4. Novel Targets for the Treatment of Melanoma.

Authors: Lara Ambrosi; Shaheer Khan; Richard D Carvajal; Jessica Yang
Journal: Curr Oncol Rep Date: 2019-11-06 Impact factor: 5.075

5. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.

Authors: Veronika Jenei; Victoria Sherwood; Jillian Howlin; Rickard Linnskog; Annette Säfholm; Lena Axelsson; Tommy Andersson
Journal: Proc Natl Acad Sci U S A Date: 2009-11-09 Impact factor: 11.205

Focus on melanoma.

1. MMP2 expression is a prognostic marker for primary melanoma patients.

2. Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

Review 3. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.

Review 4. Novel Targets for the Treatment of Melanoma.

5. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion.

6. Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.

7. The regulation of miRNA-211 expression and its role in melanoma cell invasiveness.

Review 8. Was skin cancer a selective force for black pigmentation in early hominin evolution?

9. Genome-wide screen of promoter methylation identifies novel markers in melanoma.

10. Reduced Apaf-1 expression in human cutaneous melanomas.